Evidentic • Therapeutic Indications • Bone Resorption
Bone resorption is a process involving the breakdown of bone (causing bones to become brittle). This process is done by specialized cells known as osteoclasts. As people age, the rate of resorption tends to exceed the rate of replacement. It occurs in menopausal women (with hormone imbalances) and in men who have an increased risk for fractures (broken bones).
Showing all 8 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
---|---|---|---|---|---|---|---|---|---|---|
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
-80°C |
11/2018 |
462,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
-80°C |
07/2019 |
462,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
-80°C |
10/2019 |
462,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
-80°C |
04/2020 |
462,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
-80°C |
09/2020 |
462,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
-80°C |
01/2021 |
547,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
2-8°C / -80°C |
06/2022 |
598,00Â € |
||
RANKL |
Monoclonal Antibody |
Prolia® |
60 mg/mL |
– |
3 mg |
2-8°C / -80°C |
10/2022 |
598,00Â € |
Let us know about your inquiry details and we’ll contact you shortly.